HR Execs on the Move

Tmunity

www.tmunity.com

 
Our vision is to become the leading innovative global life-sciences company that unlocks the potential of T-cell biology and combines it with the power of T-cell engineering excellence to provide cures for patients. Through our model of seamless and rapid integration of research, translational medicine, manufacturing science, clinical development and customer-centric approaches, we will design and deliver enhanced state-of-the-art solutions for patients in a host of disease areas using Chimeric Antigen Receptors (CARs), Gene edited T-Cells, T regulatory cells (Treg), and engineered T Cell Receptors (TCRs)
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.tmunity.com
  • 3020 Market Street Suite 535
    Philadelphia, PA USA 19104
  • Phone: 215.966.1600

Executives

Name Title Contact Details
Vijay Peddareddigari
Chief Research and Development Officer Profile
Lauren Gordon
Executive Director, Human Resources Profile
Lauren Gordon
Chief People Officer Profile
Usman Azam
President and Chief Executive Officer Profile

Similar Companies

bioMASON

We build with carbon the same way nature does. Our biocement® materials are healthier for us and the Planet.

VBI Vaccines

VBI Vaccines Inc.is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.

GentiBio

GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases.

Aristea Therapeutics

Aristea Therapeutics (Air-iss-tay-uh) is a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases.

ESSA Pharma

As a clinical-stage pharmaceutical company founded on cutting-edge research, ESSA is focused on developing novel therapeutics for cancer patients. ESSA embraces innovation not only in our products but also in our approach. We re firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company.